Suzhou Fushilai Pharmaceutical (301258.SZ) Obtains European CEP Certificate for Active Pharmaceutical Ingredients
Fosun Pharma (301258.SZ) announcement, the company has received a notification from the European Medicines Agency (EMA) regarding...
Suzhou Fushilai Pharmaceutical (301258.SZ) announced that the company has received the Certificate of Suitability (CEP) for the European Pharmacopoeia for the raw material drug Lipoic Acid issued by the European Directorate for Quality Medicines (EDQM). The manufacturer of Lipoic Acid is STADA in Germany, a compound belonging to the vitamin category, mainly used for diabetic polyneuropathy.
Related Articles
Northeast: Music ecosystem giant NETEASE MUSIC (09899) benefits from rapid industry growth.
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Northeast: Music ecosystem giant NETEASE MUSIC (09899) benefits from rapid industry growth.
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
